Literature DB >> 30803963

Post-Transplant Lymphoproliferative Disorder in a Kidney Transplant Recipient.

Gaurav Agarwal1, Roslyn B Mannon2.   

Abstract

Entities:  

Keywords:  EBV; PTLD; immunosuppression; kidney transplantation

Year:  2019        PMID： 30803963      PMCID： PMC6500951          DOI： 10.2215/CJN.00180119

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN： 1555-9041            Impact factor:   8.237


× No keyword cloud information.
  10 in total

Review 1.  Management of post-transplant lymphoproliferative disorder in adult solid organ transplant recipients - BCSH and BTS Guidelines.

Authors:  Anne Parker; Kristin Bowles; J Andrew Bradley; Vincent Emery; Carrie Featherstone; Girish Gupte; Robert Marcus; Jayan Parameshwar; Alan Ramsay; Charles Newstead
Journal:  Br J Haematol       Date:  2010-04-16       Impact factor: 6.998

2.  The Impact of EBV Status on Characteristics and Outcomes of Posttransplantation Lymphoproliferative Disorder.

Authors:  M R Luskin; D S Heil; K S Tan; S Choi; E A Stadtmauer; S J Schuster; D L Porter; R H Vonderheide; A Bagg; D F Heitjan; D E Tsai; R Reshef
Journal:  Am J Transplant       Date:  2015-05-18       Impact factor: 8.086

Review 3.  Polyclonal and monoclonal antibodies for induction therapy in kidney transplant recipients.

Authors:  Penny Hill; Nicholas B Cross; A Nicholas R Barnett; Suetonia C Palmer; Angela C Webster
Journal:  Cochrane Database Syst Rev       Date:  2017-01-11

Review 4.  Post-Transplantation Lymphoproliferative Disorders in Adults.

Authors:  Daan Dierickx; Thomas M Habermann
Journal:  N Engl J Med       Date:  2018-02-08       Impact factor: 91.245

5.  A French Cohort Study of Kidney Retransplantation after Post-Transplant Lymphoproliferative Disorders.

Authors:  Sophie Caillard; Etienne Cellot; Jacques Dantal; Olivier Thaunat; François Provot; Bénédicte Janbon; Matthias Buchler; Dany Anglicheau; Pierre Merville; Philippe Lang; Luc Frimat; Charlotte Colosio; Eric Alamartine; Nassim Kamar; Anne Elisabeth Heng; Antoine Durrbach; Valérie Moal; Joseph Rivalan; Isabelle Etienne; Marie Noelle Peraldi; Anne Moreau; Bruno Moulin
Journal:  Clin J Am Soc Nephrol       Date:  2017-08-17       Impact factor: 8.237

6.  Association of immunosuppressive maintenance regimens with posttransplant lymphoproliferative disorder in kidney transplant recipients.

Authors:  Marcelo Santos Sampaio; Yong W Cho; Tariq Shah; Suphamai Bunnapradist; Ian V Hutchinson
Journal:  Transplantation       Date:  2012-01-15       Impact factor: 4.939

7.  Response to Rituximab Induction Is a Predictive Marker in B-Cell Post-Transplant Lymphoproliferative Disorder and Allows Successful Stratification Into Rituximab or R-CHOP Consolidation in an International, Prospective, Multicenter Phase II Trial.

Authors:  Ralf U Trappe; Daan Dierickx; Heiner Zimmermann; Franck Morschhauser; Peter Mollee; Jan M Zaucha; Martin H Dreyling; Ulrich Dührsen; Petra Reinke; Gregor Verhoef; Marion Subklewe; Andreas Hüttmann; Thomas Tousseyn; Gilles Salles; Volker Kliem; Ingeborg A Hauser; Corrado Tarella; Eric Van Den Neste; Olivier Gheysens; Ioannis Anagnostopoulos; Veronique Leblond; Hanno Riess; Sylvain Choquet
Journal:  J Clin Oncol       Date:  2016-12-19       Impact factor: 44.544

Review 8.  Cancer incidence and risk factors after solid organ transplantation.

Authors:  Claire M Vajdic; Marina T van Leeuwen
Journal:  Int J Cancer       Date:  2009-10-15       Impact factor: 7.396

9.  Lymphomas after solid organ transplantation: a collaborative transplant study report.

Authors:  Gerhard Opelz; Bernd Döhler
Journal:  Am J Transplant       Date:  2004-02       Impact factor: 8.086

10.  Donor or recipient origin of posttransplant lymphoproliferative disorders following solid organ transplantation.

Authors:  A Kinch; L Cavelier; M Bengtsson; E Baecklund; G Enblad; C Backlin; U Thunberg; C Sundström; K Pauksens
Journal:  Am J Transplant       Date:  2014-10-10       Impact factor: 8.086
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.